Is TMS Covered by Insurance?
What insurers commonly require before approving TMS for depression, what prior authorization involves, and how off-label use affects coverage.
- Author:
- Inglewood TMS Center Editorial Team
- Medically reviewed by:
- Robin Riley-Garner, PA-C
- Published:
- September 6, 2026 ·
- Updated:
- September 6, 2026
- Reading time:
- 5 min read
This article is in preparation
We publish clinical content only once it has been written and reviewed, with sources cited. Here's what this piece will cover — and in the meantime, our main education pages already answer most of it.
What this article will cover
- 1Why coverage varies by plan
- 2Documentation insurers commonly request
- 3Prior authorization, step by step
- 4Why off-label use is usually cash-pay
- 5How to start a benefits check
Read now instead
TMS therapy in Inglewood · TMS for depression · How TMS works · FAQ
Sources & references
- Sources to be added with the full article.
Educational content only, and not a substitute for medical advice, diagnosis, or treatment. We do not publish medical statistics without a cited source. Always speak with a qualified clinician about your own situation.
In the United States, EXOMIND is intended for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. Individual results vary. TMS is not a cure, and no outcome is guaranteed. This page is patient education, not medical advice.
If you or someone you know is in immediate danger or experiencing a mental health crisis, call or text 988 or call 911.
Related articles
- TMS vs Antidepressants: What's the Difference?
A neutral look at systemic medication versus targeted stimulation — schedules, side effect profiles, and why the two are often used together.
- What Is Treatment-Resistant Depression?
The phrase describes how a condition has responded to treatment so far — not a verdict on you. Here's what it means clinically and what comes next.